Last reviewed · How we verify
NCT05834894: MEMO
Does Muscle Mass At Intensive Care Unit Admission Determine Mortality: the Memo Study
trial testing exposure(s) of interest : intensive care unit in Lean Body Mass in 4,000 participants. Participants enrolled and being followed up; not accepting new ones.
31 May 2025
Quick facts
| Lead sponsor | University Hospital, Geneva |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 4,000 |
| Start date | 1 January 2010 |
| Primary completion | 31 May 2025 |
| Estimated completion | 31 October 2025 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- exposure(s) of interest : intensive care unit
Conditions studied
- Lean Body Mass — all drugs for Lean Body Mass →
Sponsor
University Hospital, Geneva
Who can join
18 and older, any sex, with Lean Body Mass. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This retrospective monocentric study aims to investigate whether a low muscle mass at ICU admission and its loss over the ICU stay predicts mortality, and in what proportion we can counteract it by nutritional support.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Exploring the association between computed tomography (CT)-derived skeletal muscle mass and short- and long-term mortality in critically ill patients: a systematic review and meta-analysis.
Bertoni Maluf VA, Herrmann FR, Platon A, Mendes A, et al · · 2025 · cited 3× · PMID 40462133 · DOI 10.1186/s13054-025-05427-2 -
Obesity is associated with lower 30-day mortality in critically ill patients: A retrospective study of over 5400 patients.
Genton L, Bertoni Maluf VA, Herrmann FR, Prado CM, et al · · 2025 · cited 1× · PMID 40602605 · DOI 10.1016/j.clnesp.2025.06.046
Verify or expand the search:
- PubMed search for NCT05834894
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Geneva trials
Trials by the same sponsor.
- NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
- NCT07267624 — EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) · NA · not yet recruiting
- NCT06710210 — Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventi · NA · not yet recruiting
- NCT07173348 — Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea · NA · not yet recruiting
- NCT07129655 — Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Ch · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05834894 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Geneva
- Last refreshed: 6 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05834894.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing